| Financial Year |
March 31 2023 |
| Monetary Funds |
777,498,660.86 |
| Held-for-trading Financial Assets |
105,907,414.38 |
| Notes Receivable |
-- |
| Accounts Receivable |
534,036,263.97 |
| Advances to Suppliers |
18,886,913.65 |
| Other Receivables |
69,689,049.01 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,898,589,930.29 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
19,223,723.32 |
| Total Current Assets |
3,460,868,305.43 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
642,785.22 |
| Fixed Assetes |
1,129,286,105.27 |
| Under-construction Projects |
71,151,279.59 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
97,444,311.96 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,581,502.98 |
| Deferred Income Tax Assets |
10,112,055.68 |
| Other Non-Current Assets |
18,471,793.00 |
| Sub-Total of Non-Current Assets |
1,338,236,447.94 |
| Total Assets |
4,799,104,753.37 |
| Short-Term Loans |
625,095,350.17 |
| Trading Financial liabilities |
3,591,503.14 |
| Notes Payable |
180,616,565.41 |
| Accounts Payable |
415,149,024.13 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
62,048,065.32 |
| Taxes Payable |
33,867,160.10 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
50,268,642.37 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
5,754,953.77 |
| Other Current Liabilities |
6,044,783.04 |
| Sub-Total of Current Liabilities |
1,448,464,975.77 |
| Long-term Loans |
180,147,125.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
720,664.08 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
195,937,160.47 |
| Total Liabilities |
1,644,402,136.24 |
| Paid-In Capital(Or Share Stock) |
511,746,388.00 |
| Capital Surplus |
1,048,893,148.61 |
| Surplus Reserve |
156,773,313.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,334,033,362.28 |
| Minority Stockholder's Interest |
105,877,210.46 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,048,825,406.67 |
| Owner's Equity（Stockholder's Equity） |
3,154,702,617.13 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,799,104,753.37 |
